# Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation

Study · id `cardio:ct-nct01045668` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01045668](<https://clinicaltrials.gov/study/NCT01045668>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01045668

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT01045668. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2013-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT01045668, source copy `cardio:ctgov-nct01045668-2014-08-25`, retrieved 2026-10-26)
- Start date: 2010-01 (registry gives no type) (ClinicalTrials.gov record NCT01045668, source copy `cardio:ctgov-nct01045668-2014-08-25`, retrieved 2026-10-26)
- Primary completion: 2013-07 (actual) (ClinicalTrials.gov record NCT01045668, source copy `cardio:ctgov-nct01045668-2014-08-25`, retrieved 2026-10-26)
- Completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01045668, source copy `cardio:ctgov-nct01045668-2014-08-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01045668, source copy `cardio:ctgov-nct01045668-2014-08-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01045668-2014-08-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation
- Acronym: VISTA
- Condition: Ventricular Tachycardia
- Intervention (Procedure): Radiofrequency Catheter Ablation (RFCA)
- Intervention (Procedure): Radiofrequency Catheter Ablation (RFCA)
- Lead sponsor: Texas Cardiac Arrhythmia Research Foundation
- Lead sponsor class: OTHER
- Collaborator: University of Kansas
- Collaborator class: OTHER
- Collaborator: California Pacific Medical Center
- Collaborator class: OTHER
- Collaborator: Stanford University
- Collaborator class: OTHER
- Collaborator: Case Western Reserve University
- Collaborator class: OTHER
- Collaborator: Southlake Health
- Collaborator class: OTHER
- Collaborator: Catholic University, Italy
- Collaborator class: OTHER
- Collaborator: Ospedale dell'Angelo, Venezia-Mestre
- Collaborator class: OTHER
- Collaborator: RCCS Monzino Hospital, Milan, Italy
- Collaborator class: UNKNOWN
- Collaborator: University of Rome Tor Vergata
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Texas Cardiac Arrhythmia Research Foundation (`cardio:org-texas-cardiac-arrhythmia-research-foundation`)
- Registry lists this organization as a collaborator: University of Kansas (`cardio:org-university-of-kansas`)
- Registry lists this organization as a collaborator: California Pacific Medical Center (`cardio:org-california-pacific-medical-center`)
- Registry lists this organization as a collaborator: Stanford University (`cardio:org-stanford-university`)
- Registry lists this organization as a collaborator: Case Western Reserve University (`cardio:org-case-western-reserve-university`)
- Registry lists this organization as a collaborator: Southlake Health (`cardio:org-southlake-health`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ablation of Stable VTs Versus Substrate Ablation in Ischemic Cardiomyopathy: The VISTA Randomized Multicenter Trial (`cardio:pubmed-26718674`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ec7934dfd9b341adbd5a31a5deb2520c13f62b269e1936a387fe10c75ed57e40
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
